Trial Profile
ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease - A Randomized Prospective Trial (RIO-Trial)
Status:
Active, no longer recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 24 Aug 2020
Price :
$35
*
At a glance
- Drugs Abciximab (Primary)
- Indications Embolism and thrombosis; Peripheral arterial occlusive disorders
- Focus Therapeutic Use
- Acronyms RIO
- 02 Oct 2006 Status change
- 31 Dec 2005 New trial record.